USD527817S1 - Inhaler - Google Patents

Inhaler Download PDF

Info

Publication number
USD527817S1
USD527817S1 US29/216,781 US21678104F USD527817S US D527817 S1 USD527817 S1 US D527817S1 US 21678104 F US21678104 F US 21678104F US D527817 S USD527817 S US D527817S
Authority
US
United States
Prior art keywords
inhaler
shown
perspective view
view
front perspective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/216,781
Inventor
Dominik Ziegler
Grant Smetham
Mauro Citerio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB3017290 priority Critical
Application filed by Novartis AG filed Critical Novartis AG
Assigned to NOVARTIS AG reassignment NOVARTIS AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SMETHAM, GRANT, CITERIO, MAURO, ZIEGLER, DOMINIK
Application granted granted Critical
Publication of USD527817S1 publication Critical patent/USD527817S1/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a front perspective view of an inhaler showing our new design;

FIG. 2 is a rear elevational view of the inhaler shown in FIG. 1;

FIG. 3 is a right side elevational view of the inhaler shown in FIG. 1, the left side being a mirror image of the left side;

FIG. 4 is a top plan view of the inhaler shown in FIG. 1;

FIG. 5 is a bottom plan view of the inhaler shown in FIG. 1;

FIG. 6 is a front perspective view of the cap removed from the base of the inhaler shown in FIG. 1;

FIG. 7 is a rear perspective view of the cap removed from the base of the inhaler to show the mouthpiece;

FIG. 8 is a front perspective view of the inhaler portion shown with the mouthpiece shown in an open position; and,

FIG. 9 is a top plan view thereof.

Claims (1)

  1. The ornamental design of an inhaler, as shown and described.
US29/216,781 2004-05-13 2004-11-09 Inhaler Active USD527817S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB3017290 2004-05-13

Publications (1)

Publication Number Publication Date
USD527817S1 true USD527817S1 (en) 2006-09-05

Family

ID=36939955

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/216,781 Active USD527817S1 (en) 2004-05-13 2004-11-09 Inhaler

Country Status (2)

Country Link
US (1) USD527817S1 (en)
CA (1) CA108975S (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD641076S1 (en) * 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
USD733288S1 (en) * 2012-12-13 2015-06-30 Interquim, S.A. Inhalator
USD744826S1 (en) * 2013-11-18 2015-12-08 Novartis Ag Container for storage
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
USD841153S1 (en) * 2016-04-21 2019-02-19 Rohto Pharmaceutical Co., Ltd. Child-proof cap for an eye drop container
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin

Cited By (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8912193B2 (en) 2008-06-13 2014-12-16 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8499757B2 (en) 2008-06-13 2013-08-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9393372B2 (en) 2008-06-13 2016-07-19 Mannkind Corporation Dry powder drug delivery system
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US8636001B2 (en) 2008-06-13 2014-01-28 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
USD711528S1 (en) 2010-03-26 2014-08-19 Oriel Therapeutics, Inc. Dry powder inhaler
USD641076S1 (en) * 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
USD745660S1 (en) 2010-03-26 2015-12-15 Oriel Therapeutics, Inc. Dry powder inhaler
USD684684S1 (en) * 2010-03-26 2013-06-18 Oriel Therapeutics, Inc. Dry powder inhaler
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
USD733288S1 (en) * 2012-12-13 2015-06-30 Interquim, S.A. Inhalator
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
USD744826S1 (en) * 2013-11-18 2015-12-08 Novartis Ag Container for storage
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
USD841153S1 (en) * 2016-04-21 2019-02-19 Rohto Pharmaceutical Co., Ltd. Child-proof cap for an eye drop container

Also Published As

Publication number Publication date
CA108975S (en) 2007-01-11

Similar Documents

Publication Publication Date Title
USD525643S1 (en) Eyeglasses
USD524355S1 (en) Eyeglasses
USD559854S1 (en) Image for a digital camera
USD521641S1 (en) Electrosurgical pencil with three button control
USD529044S1 (en) Media device
USD517554S1 (en) Film scanner
USD526568S1 (en) Cosmetic container
USD527636S1 (en) Cosmetic container
USD514222S1 (en) Inhaler
USD509321S1 (en) Razor
USD509898S1 (en) Inhaler
USD492785S1 (en) Mouthpiece
USD560497S1 (en) Container
USD502945S1 (en) Personal digital assistant
USD531451S1 (en) Mug
USD548601S1 (en) Container with cap
USD522372S1 (en) Bottle
USD550835S1 (en) Atomizer for inhaler
USD582543S1 (en) Inhaler
USD509296S1 (en) Inhaler
USD535191S1 (en) Tube
USD557799S1 (en) Inhaler
USD512777S1 (en) Inhaler
USD515203S1 (en) Inhalation device
USD529605S1 (en) Inhalation device